Literature DB >> 21557734

Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.

Matthias Barton1, Oliver Baretella, Matthias R Meyer.   

Abstract

UNLABELLED: Obesity has become a serious global health issue affecting both adults and children. Recent devolopments in world demographics and declining health status of the world's population indicate that the prevalence of obesity will continue to increase in the next decades. As a disease, obesity has deleterious effects on metabolic homeostasis, and affects numerous organ systems including heart, kidney and the vascular system. Thus, obesity is now regarded as an independent risk factor for atherosclerosis-related diseases such as coronary artery disease, myocardial infarction and stroke. In the arterial system, endothelial cells are both the source and target of factors contributing to atherosclerosis. Endothelial vasoactive factors regulate vascular homeostasis under physiological conditions and maintain basal vascular tone. Obesity results in an imbalance between endothelium-derived vasoactive factors favouring vasoconstriction, cell growth and inflammatory activation. Abnormal regulation of these factors due to endothelial cell dysfunction is both a consequence and a cause of vascular disease processes. Finally, because of the similarities of the vascular pathomechanisms activated, obesity can be considered to cause accelerated, 'premature' vascular aging. Here, we will review some of the pathomechanisms involved in obesity-related activation of endothelium-dependent vasoconstriction, the clinical relevance of obesity-associated vascular risk, and therapeutic interventions using 'endothelial therapy' aiming at maintaining or restoring vascular endothelial health. LINKED ARTICLES: This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-3.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2012        PMID: 21557734      PMCID: PMC3315033          DOI: 10.1111/j.1476-5381.2011.01472.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  156 in total

1.  Obesity rising to alarming levels around the world.

Authors:  Faith McLellan
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

Review 2.  Treatment recommendations for prediabetes.

Authors:  Robert E Ratner; Anpalakan Sathasivam
Journal:  Med Clin North Am       Date:  2011-03       Impact factor: 5.456

3.  Production of C-type natriuretic peptide in human aortic endothelial cells induced by activation of protein kinase C.

Authors:  Y Yamada; M Yokota
Journal:  Am J Hypertens       Date:  1996-09       Impact factor: 2.689

4.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.

Authors:  K A Hickey; G Rubanyi; R J Paul; R F Highsmith
Journal:  Am J Physiol       Date:  1985-05

5.  Metabolic health, obesity and 9-year incidence of peripheral arterial disease: the D.E.S.I.R. study.

Authors:  Michael R Skilton; Jaye P F Chin-Dusting; Anthony M Dart; Laima Brazionis; Olivier Lantieri; Kerin O'Dea; Beverley Balkau
Journal:  Atherosclerosis       Date:  2011-02-24       Impact factor: 5.162

6.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

7.  Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.

Authors:  T Nilsson; H Lind; J Brunkvall; L Edvinsson
Journal:  Can J Physiol Pharmacol       Date:  2000-03       Impact factor: 2.273

8.  Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase.

Authors:  R M Wever; T van Dam; H J van Rijn; F de Groot; T J Rabelink
Journal:  Biochem Biophys Res Commun       Date:  1997-08-18       Impact factor: 3.575

9.  Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.

Authors:  Carmine Cardillo; Umberto Campia; Micaela Iantorno; Julio A Panza
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Adolescent overweight and future adult coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

View more
  26 in total

1.  Obesity and vascular dysfunction: the fat-e of rich and poor.

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.

Authors:  Chayanut Suwanpen; Phonethipsavanh Nouanthong; Veeravich Jaruvongvanich; Krit Pongpirul; Wannarat Amornnimit Pongpirul; Asada Leelahavanichkul; Talerngsak Kanjanabuch
Journal:  J Nephrol       Date:  2015-04-24       Impact factor: 3.902

3.  Obesity causes lymphatic vascular injury: time for clinical translation.

Authors:  Matthias Barton; Marc Husmann
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

Review 4.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

5.  Octacosanol enhances the proliferation and migration of human umbilical vein endothelial cells via activation of the PI3K/Akt and MAPK/Erk pathways.

Authors:  Yu-Wei Liu; Pei-Yuan Zuo; Xiang-Nan Zha; Xing-Lin Chen; Rong Zhang; Xiao-Xiao He; Cheng-Yun Liu
Journal:  Lipids       Date:  2015-02-01       Impact factor: 1.880

6.  Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.

Authors:  Matthias R Meyer; Kerstin Amann; Angela S Field; Chelin Hu; Helen J Hathaway; Nancy L Kanagy; Mary K Walker; Matthias Barton; Eric R Prossnitz
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

7.  Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.

Authors:  Andreas M Beyer; Gabor Raffai; Brian Weinberg; Katherine Fredrich; Julian H Lombard
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

8.  Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.

Authors:  Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Linnea R Freeman; Jennifer K Pepping; Tina L Beckett; M Paul Murphy; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2013-01-09

9.  Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries.

Authors:  Oliver Baretella; Aimin Xu; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

10.  Association of sleep apnea and sleep duration with peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mako Nagayoshi; Pamela L Lutsey; David Benkeser; Christina L Wassel; Aaron R Folsom; Eyal Shahar; Hiroyasu Iso; Matthew A Allison; Michael H Criqui; Susan Redline
Journal:  Atherosclerosis       Date:  2016-06-25       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.